scispace - formally typeset
S

Stefan Martinoff

Researcher at Technische Universität München

Publications -  129
Citations -  8295

Stefan Martinoff is an academic researcher from Technische Universität München. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 40, co-authored 120 publications receiving 7871 citations. Previous affiliations of Stefan Martinoff include Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

Estimated Radiation Dose Associated With Cardiac CT Angiography

TL;DR: In this article, a cross-sectional, international, multicenter, observational study was conducted to estimate the radiation dose of CCTA in routine clinical practice as well as the association of currently available strategies with dose reduction.
Journal Article

Estimated Radiation Dose Associated With Cardiac CT Angiography. Commentary

TL;DR: The comparable diagnostic image quality of CCTA may support an increased use of dose-saving strategies in adequately selected patients and effective strategies to reduce radiation dose are available but some strategies are not frequently used.
Journal ArticleDOI

Radiation dose estimates from cardiac multislice computed tomography in daily practice: impact of different scanning protocols on effective dose estimates.

TL;DR: The increase in spatial and temporal resolution with 64-slice CTA is associated with an increased radiation dose for coronary CTA and dose-saving algorithms are very effective in reducing radiation exposure.
Journal ArticleDOI

Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

TL;DR: In patients with acute myocardial infarction, coronary stenting plus abciximab leads to a greater degree ofMyocardial salvage and a better clinical outcome than does fibrinolysis with a tissue plasminogen activator.
Journal ArticleDOI

Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.

TL;DR: Upstream administration of abciximab is not associated with a reduction in infarct size in patients presenting with acute myocardial infarction within 24 hours of symptom onset and receiving 600 mg clopidogrel.